Pelargonium Extract EPs 7630 in the Treatment of Human Corona Virus-Associated Acute Respiratory Tract Infections – A Secondary Subgroup-Analysis of an Open-Label, Uncontrolled Clinical Trial

Background: Experience in treating human coronavirus (HCoV) infections might help to identify effective compounds against novel coronaviruses. We therefore performed a secondary subgroup-analysis of data from an open-label, uncontrolled clinical trial published in 2015 investigating the proanthocyan...

Descripción completa

Detalles Bibliográficos
Autores principales: Keck, Tilman, Strobl, Andreas, Weinhaeusel, Andreas, Funk, Petra, Michaelis, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120433/
https://www.ncbi.nlm.nih.gov/pubmed/33995094
http://dx.doi.org/10.3389/fphar.2021.666546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120433/
https://www.ncbi.nlm.nih.gov/pubmed/33995094
http://dx.doi.org/10.3389/fphar.2021.666546

Ejemplares similares